Desmethyl Fruquintinib Impurity - Request Quote
Desmethyl Fruquintinib Impurity
| SZ CAT No: | SZ-F116004 |
| CAS No | NA |
| Mol.F. | C20H17N3O5 |
| Mol.Wt. | 379.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Desmethyl Fruquintinib Impurity is chemically 6-((6,7-Dimethoxyquinazolin-4-yl)oxy)-2-methylbenzofuran-3-carboxamide. Desmethyl Fruquintinib Impurity is supplied with detailed characterization data compliant with regulatory guideline. Desmethyl Fruquintinib Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fruquintinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Desmethyl Fruquintinib Impurity
Purchase Desmethyl Fruquintinib Impurity
Desmethyl Fruquintinib Impurity suppliers
Desmethyl Fruquintinib Impurity manufacturers
Desmethyl Fruquintinib Impurity price
Order Desmethyl Fruquintinib Impurity
Enquire Desmethyl Fruquintinib Impurity
Desmethyl Fruquintinib Impurity cost
Desmethyl Fruquintinib Impurity Supplier
Desmethyl Fruquintinib Impurity Distributor
Desmethyl Fruquintinib Impurity for Method Validation
Fruquintinib Reference Standard
Desmethyl Fruquintinib Impurity for ANDA Filing
Desmethyl Fruquintinib Impurity for Forced Degradation Studies
Desmethyl Fruquintinib Impurity Identification Standards
Desmethyl Fruquintinib Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.